Y. Lam

发表

Lack of CYP3A4 Inhibition by Grapefruit Juice and Ketoconazole upon Clozapine Administration in Vivo

M. Jann, H. Lane, Hsieh-Yuan Lane, 2001, Drug metabolism and drug interactions.

Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients

M. Jann, H. Lane, Shih-ku Lin, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Correlation of Cytochrome P450 (CYP) 1A2 Activity Using Caffeine Phenotyping and Olanzapine Disposition in Healthy Volunteers

M. Jann, Y. Hon, S. Penzak, 2003, Neuropsychopharmacology.

Future Directions for Pharmacogenetics

M. Jann, Y. Lam, 1993 .

REVERSIBLE METABOLISM OF DRUGS

M. Jann, Y. Lam, Wen‐Ho Chang, 1994, Drug metabolism and drug interactions.

The pharmacokinetics of teicoplanin in varying degrees of renal function

M. Sande, M. Sachdeva, C. Hackbarth, 1990, Clinical pharmacology and therapeutics.

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients

M. Jann, Y. Lam, Chang Wen-ho, 1989, Biological Psychiatry.

Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populations

H. Hwu, M. Jann, L. Ereshefsky, 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Disposition of Clozapine and Desmethylclozapine in Schizophrenic Patients

M. Jann, Shih-ku Lin, S. K. Lin, 1994, Journal of clinical pharmacology.

Intra‐ and Interethnic Variability in Reduced Haloperidol to Haloperidol Ratios

M. Jann, C. Davis, Shih-ku Lin, 1995, Journal of clinical pharmacology.

Formation of Reduced Haloperidol after Intramuscular Haloperidol Administration in Schizophrenic Patients

M. Jann, Shih-ku Lin, Y. Lam, 1994 .

Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics

M. Jann, Y. Lam, Hu Wei-Herng, 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Disposition of haloperidol and reduced haloperidol plasma levels after single dose haloperidol decanoate administration

Shih-ku Lin, C. Chien, Y. Lam, 1995 .

Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawal

M. Jann, Shih-ku Lin, Y. Lam, 1993, Schizophrenia Research.

Pharmacokinetics of Haloperidol

M. Jann, C. Davis, Y. Lam, 1989, Clinical pharmacokinetics.

Lack of Pharmacokinetic Interaction Between Buspirone and Haloperidol in Patients with Schizophrenia

M. Jann, Shih-ku Lin, C. Chien, 1996, Journal of clinical pharmacology.